Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Obtaining a Correct Diagnosis Rapidly in the United States Is Associated With Many Barriers Not Present in Other Countries.

Laposata M.

Am J Clin Pathol. 2018 Apr 25;149(6):458-460. doi: 10.1093/ajcp/aqy010. No abstract available.

PMID:
29635278
2.

What's New in Laboratory Test Utilization Management?

Baird GS, Jackson BR, Dickerson J, Sikaris K, Croal B, Laposata M.

Clin Chem. 2018 Apr 9. pii: clinchem.2017.280214. doi: 10.1373/clinchem.2017.280214. [Epub ahead of print] No abstract available.

PMID:
29632128
3.

The new diagnostic team.

Graber ML, Rusz D, Jones ML, Farm-Franks D, Jones B, Cyr Gluck J, Thomas DB, Gleason KT, Welte K, Abfalter J, Dotseth M, Westerhaus K, Smathers J, Adams G, Laposata M, Nabatchi T, Compton M, Eichbaum Q.

Diagnosis (Berl). 2017 Nov 27;4(4):225-238. doi: 10.1515/dx-2017-0022.

PMID:
29536943
5.

In Reply.

Laposata M.

Arch Pathol Lab Med. 2018 Feb;142(2):158b-159. doi: 10.5858/arpa.2017-0379-LE. No abstract available.

PMID:
29372847
6.

Why have doctors stopped asking for autopsies? Will a different type of autopsy change this?

Laposata M.

Autops Case Rep. 2017 Sep 30;7(3):1-2. doi: 10.4322/acr.2017.023. eCollection 2017 Jul-Sep. No abstract available.

7.

A New Kind of Autopsy for 21st Century Medicine.

Laposata M.

Arch Pathol Lab Med. 2017 Jul;141(7):887-888. doi: 10.5858/arpa.2016-0317-ED. No abstract available.

PMID:
28661212
8.

A comparison of red blood cell transfusion utilization between anti-activated factor X and activated partial thromboplastin monitoring in patients receiving unfractionated heparin.

Belk KW, Laposata M, Craver C.

J Thromb Haemost. 2016 Nov;14(11):2148-2157. doi: 10.1111/jth.13476. Epub 2016 Oct 28.

PMID:
27543785
9.

Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study.

O'Connor MG, Thomsen K, Brown RF, Laposata M, Seegmiller A.

Prostaglandins Leukot Essent Fatty Acids. 2016 Oct;113:46-49. doi: 10.1016/j.plefa.2016.08.011. Epub 2016 Aug 27.

10.

Insufficient Teaching of Laboratory Medicine in US Medical Schools.

Laposata M.

Acad Pathol. 2016 Mar 3;3:2374289516634108. doi: 10.1177/2374289516634108. eCollection 2016 Jan-Dec. No abstract available.

11.

It's Our Turn: Implications for Pathology From the Institute of Medicine's Report on Diagnostic Error.

Laposata M, Cohen MB.

Arch Pathol Lab Med. 2016 Jun;140(6):505-7. doi: 10.5858/arpa.2015-0499-ED. Epub 2016 Jan 12. No abstract available.

PMID:
26756648
12.

Physician response to implementation of genotype-tailored antiplatelet therapy.

Peterson JF, Field JR, Unertl KM, Schildcrout JS, Johnson DC, Shi Y, Danciu I, Cleator JH, Pulley JM, McPherson JA, Denny JC, Laposata M, Roden DM, Johnson KB.

Clin Pharmacol Ther. 2016 Jul;100(1):67-74. doi: 10.1002/cpt.331. Epub 2016 Feb 17.

13.

Attitudes of clinicians following large-scale pharmacogenomics implementation.

Peterson JF, Field JR, Shi Y, Schildcrout JS, Denny JC, McGregor TL, Van Driest SL, Pulley JM, Lubin IM, Laposata M, Roden DM, Clayton EW.

Pharmacogenomics J. 2016 Aug;16(4):393-8. doi: 10.1038/tpj.2015.57. Epub 2015 Aug 11.

14.

Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR-/- mice by suppressing fatty acid desaturases.

Njoroge SW, Laposata M, Boyd KL, Seegmiller AC.

J Nutr Biochem. 2015 Jan;26(1):36-43. doi: 10.1016/j.jnutbio.2014.09.001. Epub 2014 Oct 2.

PMID:
25448610
15.
16.

A prospective tool for risk assessment of sendout testing.

Cole B, Dickerson JA, Graber ML, Fantz CR, Laposata M, Henriksen K, Astion ML, Epner P.

Clin Chim Acta. 2014 Jul 1;434:1-5. doi: 10.1016/j.cca.2014.03.028. Epub 2014 Mar 29.

PMID:
24685573
17.
19.

Interactions of linoleic and alpha-linolenic acids in the development of fatty acid alterations in cystic fibrosis.

Katrangi W, Lawrenz J, Seegmiller AC, Laposata M.

Lipids. 2013 Apr;48(4):333-42. doi: 10.1007/s11745-013-3768-4. Epub 2013 Feb 27.

PMID:
23440519
20.

The isolated prolonged PTT.

Tcherniantchouk O, Laposata M, Marques MB.

Am J Hematol. 2013 Jan;88(1):82-5. doi: 10.1002/ajh.23285. Epub 2012 Jul 18.

21.

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.

Pulley JM, Denny JC, Peterson JF, Bernard GR, Vnencak-Jones CL, Ramirez AH, Delaney JT, Bowton E, Brothers K, Johnson K, Crawford DC, Schildcrout J, Masys DR, Dilks HH, Wilke RA, Clayton EW, Shultz E, Laposata M, McPherson J, Jirjis JN, Roden DM.

Clin Pharmacol Ther. 2012 Jul;92(1):87-95. doi: 10.1038/clpt.2011.371. Epub 2012 May 16.

22.

The identification and management of heparin-induced thrombocytopenia in the vascular patient.

LaMuraglia GM, Houbballah R, Laposata M.

J Vasc Surg. 2012 Feb;55(2):562-70. doi: 10.1016/j.jvs.2011.10.082. Epub 2011 Dec 20. Review.

23.

Teaching laboratory management to pathology residents: what skill set are we trying to impart?

Laposata M.

Am J Clin Pathol. 2012 Jan;137(1):16-8. doi: 10.1309/AJCPOKS9MGHW9UTJ. No abstract available.

PMID:
22180473
24.

DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activity.

Njoroge SW, Laposata M, Katrangi W, Seegmiller AC.

J Lipid Res. 2012 Feb;53(2):257-65. doi: 10.1194/jlr.M018101. Epub 2011 Nov 16.

25.

The brain-to-brain loop concept for laboratory testing 40 years after its introduction.

Plebani M, Laposata M, Lundberg GD.

Am J Clin Pathol. 2011 Dec;136(6):829-33. doi: 10.1309/AJCPR28HWHSSDNON. Review.

PMID:
22095366
26.

Test of the month: The chromogenic antifactor Xa assay.

Gehrie E, Laposata M.

Am J Hematol. 2012 Feb;87(2):194-6. doi: 10.1002/ajh.22222. Epub 2011 Nov 12.

27.

Increased Δ5- and Δ6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis.

Njoroge SW, Seegmiller AC, Katrangi W, Laposata M.

Biochim Biophys Acta. 2011 Jul-Aug;1811(7-8):431-40. doi: 10.1016/j.bbalip.2011.05.002. Epub 2011 May 13.

PMID:
21605700
28.

Increased elongase 6 and Δ9-desaturase activity are associated with n-7 and n-9 fatty acid changes in cystic fibrosis.

Thomsen KF, Laposata M, Njoroge SW, Umunakwe OC, Katrangi W, Seegmiller AC.

Lipids. 2011 Aug;46(8):669-77. doi: 10.1007/s11745-011-3563-z. Epub 2011 May 5.

29.

The clinical pathologist as consultant.

Marques MB, Anastasi J, Ashwood E, Baron B, Fitzgerald R, Fung M, Krasowski M, Laposata M, Nester T, Rinder HM; Academy of Clinical Laboratory Physicians and Scientists.

Am J Clin Pathol. 2011 Jan;135(1):11-2. doi: 10.1309/AJCP0EZMP6HJORBK. No abstract available.

PMID:
21173119
30.

Professional quality assurance in laboratory medicine: what about the competency of laboratory directors?

Laposata M, Proytcheva MA, Rutledge JC, Stratton CW.

Am J Clin Pathol. 2010 Nov;134(5):706-8. doi: 10.1309/AJCPXO7G8OHUPYHJ. No abstract available.

PMID:
20959652
31.

Linoleic acid supplementation results in increased arachidonic acid and eicosanoid production in CF airway cells and in cftr-/- transgenic mice.

Zaman MM, Martin CR, Andersson C, Bhutta AQ, Cluette-Brown JE, Laposata M, Freedman SD.

Am J Physiol Lung Cell Mol Physiol. 2010 Nov;299(5):L599-606. doi: 10.1152/ajplung.00346.2009. Epub 2010 Jul 23.

32.

Assessment of critical values policies in Italian institutions: comparison with the US situation.

Piva E, Sciacovelli L, Laposata M, Plebani M.

Clin Chem Lab Med. 2010 Apr;48(4):461-8. doi: 10.1515/CCLM.2010.096.

PMID:
20128733
33.

Successful use of bivalirudin for combined carotid endarterectomy and coronary revascularization with the use of cardiopulmonary bypass in a patient with an elevated heparin-platelet factor 4 antibody titer.

Avery EG, Hilgenberg AD, Cambria RP, Beckerly R, Donnelly AM, Laposata M.

Anesth Analg. 2009 Apr;108(4):1113-5. doi: 10.1213/ane.0b013e318196cd51.

PMID:
19299772
34.

Evaluation of effectiveness of a computerized notification system for reporting critical values.

Piva E, Sciacovelli L, Zaninotto M, Laposata M, Plebani M.

Am J Clin Pathol. 2009 Mar;131(3):432-41. doi: 10.1309/AJCPYS80BUCBXTUH.

PMID:
19228648
35.

Case records of the Massachusetts General Hospital. Case 38-2008. A 58-year-old man with hemophilia, hepatocellular carcinoma, and intractable bleeding.

Dzik WH, Laposata M, Hertl M, Sandberg WS, Chatterji M, Misdraji J.

N Engl J Med. 2008 Dec 11;359(24):2587-97. doi: 10.1056/NEJMcpc0807506. No abstract available.

PMID:
19073979
36.

A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.

Mischoulon D, Best-Popescu C, Laposata M, Merens W, Murakami JL, Wu SL, Papakostas GI, Dording CM, Sonawalla SB, Nierenberg AA, Alpert JE, Fava M.

Eur Neuropsychopharmacol. 2008 Sep;18(9):639-45. doi: 10.1016/j.euroneuro.2008.04.011. Epub 2008 Jun 6.

PMID:
18539007
37.

A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA.

Al-Turkmani MR, Andersson C, Alturkmani R, Katrangi W, Cluette-Brown JE, Freedman SD, Laposata M.

J Lipid Res. 2008 Sep;49(9):1946-54. doi: 10.1194/jlr.M800035-JLR200. Epub 2008 May 14.

38.

Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism.

Andersson C, Al-Turkmani MR, Savaille JE, Alturkmani R, Katrangi W, Cluette-Brown JE, Zaman MM, Laposata M, Freedman SD.

J Lipid Res. 2008 Aug;49(8):1692-700. doi: 10.1194/jlr.M700388-JLR200. Epub 2008 Apr 25.

39.

Induction of apoptosis and necrosis in human peripheral blood mononuclear cells by fatty acid ethyl esters.

Alhomsi K, Selig M, Sustic T, Katrangi E, Weissig V, Laposata M.

Alcohol Clin Exp Res. 2008 Mar;32(3):534-43. doi: 10.1111/j.1530-0277.2007.00597.x. Epub 2008 Jan 22.

PMID:
18215210
40.

Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.

Al-Turkmani MR, Freedman SD, Laposata M.

Prostaglandins Leukot Essent Fatty Acids. 2007 Nov-Dec;77(5-6):309-18. Epub 2007 Nov 26. Review.

PMID:
18036797
41.
42.

Proposed research training guidelines for residents in laboratory medicine.

Peerschke EI, Agrawal Y, Alexander CB, Bovill E, Laposata M.

Clin Lab Med. 2007 Jun;27(2):241-53; abstract v-vi. Review.

PMID:
17556083
43.

Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial.

Wozniak J, Biederman J, Mick E, Waxmonsky J, Hantsoo L, Best C, Cluette-Brown JE, Laposata M.

Eur Neuropsychopharmacol. 2007 May-Jun;17(6-7):440-7. Epub 2007 Jan 26.

PMID:
17258897
44.

Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.

Everett BM, Yeh R, Foo SY, Criss D, Van Cott EM, Laposata M, Avery EG, Hoffman WD, Walker J, Torchiana D, Jang IK.

Ann Thorac Surg. 2007 Feb;83(2):592-7.

PMID:
17257993
45.

Case records of the Massachusetts General Hospital. Case 1-2007. A 40-year-old woman with epistaxis, hematemesis, and altered mental status.

Laposata M, Van Cott EM, Lev MH.

N Engl J Med. 2007 Jan 11;356(2):174-82. No abstract available.

PMID:
17215536
46.

Optical measurement of cell membrane tension.

Popescu G, Ikeda T, Goda K, Best-Popescu CA, Laposata M, Manley S, Dasari RR, Badizadegan K, Feld MS.

Phys Rev Lett. 2006 Nov 24;97(21):218101. Epub 2006 Nov 20.

PMID:
17155774
47.

Potential utility of plasma fatty acid analysis in the diagnosis of cystic fibrosis.

Batal I, Ericsoussi MB, Cluette-Brown JE, O'Sullivan BP, Freedman SD, Savaille JE, Laposata M.

Clin Chem. 2007 Jan;53(1):78-84. Epub 2006 Nov 27.

49.

The total body mass of fatty acid ethyl esters in skeletal muscles following ethanol exposure greatly exceeds that found in the liver and the heart.

Salem RO, Laposata M, Rajendram R, Cluette-Brown JE, Preedy VR.

Alcohol Alcohol. 2006 Nov-Dec;41(6):598-603. Epub 2006 Sep 16.

PMID:
16980711
50.

Combination of D-dimer and amino-terminal pro-B-type natriuretic Peptide testing for the evaluation of dyspneic patients with and without acute pulmonary embolism.

Melanson SE, Laposata M, Camargo CA Jr, Chen AA, Tung R, Krauser D, Anwaruddin S, Baggish A, Cameron R, Sluss P, Lewandrowski KB, Lee-Lewandrowski E, Januzzi JL.

Arch Pathol Lab Med. 2006 Sep;130(9):1326-9.

PMID:
16948519

Supplemental Content

Loading ...
Support Center